Sacramento Angels
VC Fund
Sacramento, United States
Sacramento Angels is a VC fund in Sacramento focused on Health Care and Biotechnology. The Sacramento Angels is a membership based organization of active angel investors who invest in early-stage Northern California companies. The group meets once a month over dinner and review presentations from candidate companies. If some members show interest in a presenting company, the group facilitates their efforts to share further duediligence. Members act on their own behalf and make individual investment decisions.Sacramento Angels membership is open to individuals who are accredited investors with the experience and desire to invest in and work directly with emerging-technology companies. The members have a wide range of backgrounds, including CEO's, senior executives, entrepreneurs, attorneys and professional venture capitalists. They apply this considerable experience to assist their investments with business strategy and implementation, team building and fundraising.Interested prospective members are invited to complete and submit a membership application. Entrepreneurs whose companies are in need of angel funding should review the investment criteria.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Sacramento Angels invests in
Stages Sacramento Angels invests in
Countries Sacramento Angels invests in
Investment Focus
Industry
- Health Care 6 (26%)
- Biotechnology 4 (17%)
- Software 3 (13%)
- SaaS 2 (9%)
- Energy 2 (9%)
Stage
- Series A 7 (30%)
- Seed 4 (17%)
- Funding Round 4 (17%)
- Series B 3 (13%)
- Angel 2 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HEN Technologies
|
HEN Nozzles use fundamentals of fluid dynamics and thermal management to create firefighting nozzles. They are designed to allow the firefighter to alter the solid stream while minimizing the disruption of the thermal balance. | $8M / Seed / Oct 17, 2024 | |
Linshom Medical, Inc.
|
Linshom is first to deliver continuous respiratory monitoring, including Tidal Volume, to the patient bedside. | $2.2M / Series A / Aug 15, 2023 | |
Nalu Bio
|
Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700xless land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis. | $12M / Series A / Feb 28, 2023 | |
Identical
|
Identical is a developer of personalized dental implants used to make tooth replacement more accessible and affordable for everyone. Its implants are drill-free and non-invasive and use the latest 3D technology that enables dentists to deliver personalized dental implants in a faster and safer way.It was founded in 2018 and is headquartered inWalnut Creek, California. | Seed / Jan 24, 2023 | |
Axicle
|
Transform the heavy truck industry. | $1.3M / Nov 14, 2022 | |
|
Axicle
|
Transform the heavy truck industry. | $1.3M / Seed / Nov 14, 2022 | |
Partake Foods
|
Partake Foods is a food and beverage company that specializes in selling allergy-friendly cookies. The company's products are free of the top 12 allergens so families can eat safely, healthfully, and deliciously — even on-the-go. The company was founded in 2016 and is headquartered in Jersey City, New Jersey. | $20.8M / Series B / Oct 04, 2022 | |
Shyft
|
Shyft is transforming the moving and relocation industry by introducing state-of-art innovative technology, superior customer service, and highly efficient lead management solutions. Today, 300+ moving companies in more than 68 countries use Shyft’s sales and customer success solutions to book more moves, engage with their leads in real-time, anddeliver a delightful experience to transferees.Shyft’s Lump Sum Marketplace Platform, first of its kind, is designed exclusively for relocation management companies and corporations to help relocate employees anywhere in the world in an efficient and stress-free manner. Shyft streamlines their transferees’ experience from the first inquiry to the final invoice.Founded by industry experts with over 75 years of combined domain expertise, Shyft is a global company with offices in San Francisco, California, and Belgrade, Serbia. | $16M / Series B / Sep 15, 2022 | |
|
Axicle
|
Transform the heavy truck industry. | $1.1M / Seed / Aug 01, 2022 | |
Deep Blue Medical Advances
|
Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Their surgeon-invented mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional meshfixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, Their Anchor Clip fixation device design enables faster, stronger, easier mesh implantation. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure. | $7M / Series A / Jun 28, 2022 | |
| See all 23 investments → | |||
Co-Investors
Sierra Angels
5 deals together
Alamo Angels
3 deals together
Central Texas Angel Network
3 deals together
Paulos Holdings
3 deals together
Abell Foundation
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Sacramento Angels invest in?
Sacramento Angels invests primarily in Health Care, Biotechnology and Software startups, most often at Series A and Seed stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sacramento Angels last invest?
The most recent investment recorded for Sacramento Angels closed in Oct 2024. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
